Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaffirmed FY26 EPS guidance.
Stocks · News reference
U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal. Securitize and biotech shares rallied.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaffirmed FY26 EPS guidance.
A comprehensive market research report examines the growing role of AI tools in drug discovery, covering applications in target identification, molecular design, and preclinical testing. The market is shifting from isolated computational experiments toward integrated workflows combining data systems and laboratory validation. Success depends on data quality, model interpretability, regulatory compliance, and multidisciplinary expertise across biology, chemistry, and data science.
https://www.theinformation.com/newsletters/dealmaker/networking-startup-eliyan-draws-takeover-interest-held-early-talks-arm
ARM Holdings has recovered 11.5% over the past month, driven by accelerating AI adoption and expanding data-center demand. The company's Q1 fiscal 2027 revenues rose 22% to $1.29B with data-center royalties more than doubling. However, its forward P/S multiple of 43.54X far exceeds the semiconductor industry average of 5.14X, warranting caution. Analysts recommend holding for existing shareholders while prospective investors should await a better entry point.
Arm stock falls over 3% premarket as Qualcomm lawsuit pressure mounts. Get key technical levels, earnings outlook, and price targets.